BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Keefe SJ. Nutrition and gastrointestinal disease. Scand J Gastroenterol Suppl 1996;220:52-9. [PMID: 8898436 DOI: 10.3109/00365529609094750] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Ouahed J, Snapper S, Fuss I, Bousvaros A. Gastrointestinal Manifestations of Immunodeficiency. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00040-2] [Reference Citation Analysis]
2 Głąbska D, Guzek D, Zakrzewska P, Lech G. Intake of Lutein and Zeaxanthin as a Possible Factor Influencing Gastrointestinal Symptoms in Caucasian Individuals with Ulcerative Colitis in Remission Phase. J Clin Med 2019;8:E77. [PMID: 30641888 DOI: 10.3390/jcm8010077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
3 Prasad K, Haq R, Bansal V, Siddiqui M, Ilahy R. Chapter 4 Carrot: Secondary Metabolites and their Prospective Health Benefits. Plant Secondary Metabolites, 3 Volume Set 2016. [DOI: 10.1201/9781315207506-15] [Reference Citation Analysis]
4 Głąbska D, Guzek D, Zakrzewska P, Włodarek D, Lech G. Lycopene, Lutein and Zeaxanthin May Reduce Faecal Blood, Mucus and Pus but not Abdominal Pain in Individuals with Ulcerative Colitis. Nutrients 2016;8:E613. [PMID: 27706028 DOI: 10.3390/nu8100613] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
5 Prasad K, Haq R, Bansal V, Siddiqui MW, Ilahy4 R. Chapter 4 Carrot: Secondary Metabolites and their Prospective Health Benefits. Plant Secondary Metabolites, Volume 2 2016. [DOI: 10.1201/9781315366319-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Alowais FA, Alferayan YA, Aljehani RM. Inflammatory Bowel Disease and Quality of Life in King Abdulaziz Medical City. OJGas 2016;06:11-16. [DOI: 10.4236/ojgas.2016.61003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Sacco R, Tanaka T, Yamamoto T, Bresci G, Saniabadi AR. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. Expert Rev Gastroenterol Hepatol 2015;9:327-33. [PMID: 25160857 DOI: 10.1586/17474124.2014.953060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
8 Zou S, Li J, Ma C, Chen J, Leong P, Leung H, Chan W, Wong H, Ko K. Hawthorn Nectar Enhances Gastrointestinal Motility as Well as Stimulates Intestinal Am-ylase and Lipase Activities in Mice. CM 2015;06:159-68. [DOI: 10.4236/cm.2015.63017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715 [PMID: 25110409 DOI: 10.3748/wjg.v20.i29.9699] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
10 Jakobsdottir G, Bjerregaard JH, Skovbjerg H, Nyman M. Fasting serum concentration of short-chain fatty acids in subjects with microscopic colitis and celiac disease: no difference compared with controls, but between genders. Scand J Gastroenterol 2013;48:696-701. [PMID: 23600961 DOI: 10.3109/00365521.2013.786128] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
11 Hanai H, Iida T, Takeuchi K, Arai H, Arai O, Abe J, Tanaka T, Maruyama Y, Ikeya K, Sugimoto K, Nakamura T, Nakamura K, Watanabe F. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease. Dig Liver Dis 2012;44:649-54. [PMID: 22542605 DOI: 10.1016/j.dld.2012.03.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
12 de Oliveira Assis T, da Silva TG, de Souza Franco E, Rezende Leite AC, de Moraes SR, de Sousa Maia MB. Impact of early malnourishment on the chronic inflammatory response and its implications for the effect of indomethacin on Wistar rats. Br J Nutr 2011;106:845-51. [PMID: 21736850 DOI: 10.1017/S0007114511001127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
13 Miller TL, Cushman LL. Gastrointestinal Complications of Secondary Immunodeficiency Syndromes. Pediatric Gastrointestinal and Liver Disease 2011. [DOI: 10.1016/b978-1-4377-0774-8.10042-9] [Reference Citation Analysis]
14 Fatahzadeh M. Inflammatory bowel disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:e1-10. [PMID: 19836703 DOI: 10.1016/j.tripleo.2009.07.035] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
15 Munsell M, Mullin G. Inflammatory Bowel Disease. Food and Nutrients in Disease Management 2009. [DOI: 10.1201/9781420067637.ch14] [Reference Citation Analysis]
16 Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 2008;14:1105-11. [PMID: 18302272 DOI: 10.1002/ibd.20429] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 8.4] [Reference Citation Analysis]
17 Aloupis M, Faust T. Gastrointestinal Disorders. The Complete Guide to Nutrition in Primary Care 2008. [DOI: 10.1002/9780470691793.ch9] [Reference Citation Analysis]
18 Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnason I, Lofberg R. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfus Apher Sci. 2007;37:191-200. [PMID: 17974479 DOI: 10.1016/j.transci.2007.08.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
19 Vicario M, Amat C, Rivero M, Moretó M, Pelegrí C. Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis. J Nutr 2007;137:1931-7. [PMID: 17634266 DOI: 10.1093/jn/137.8.1931] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
20 Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
21 Kanai T, Hibi T, Watanabe M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opinion on Biological Therapy 2006;6:453-66. [DOI: 10.1517/14712598.6.5.453] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
22 Vicario M, Crespí M, Franch À, Amat C, Pelegrí C, Moretó M. Induction of Colitis in Young Rats by Dextran Sulfate Sodium. Dig Dis Sci 2005;50:143-50. [PMID: 27837390 DOI: 10.1007/s10620-005-1292-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
23 Beyer PL. Nutrient Considerations in Inflammatory Bowel Disease and Short Bowel Syndrome. Nutrition in the Prevention and Treatment of Disease 2001. [DOI: 10.1016/b978-012193155-1/50040-4] [Reference Citation Analysis]
24 Mester Á, Makó E, Karlinger K, Györke T, Márton E. high resolution computed tomography detection of alimentary factors related to arthropathies in inflammatory bowel diseases. Acta Alimentaria 1999;28:171-81. [DOI: 10.1556/aalim.28.1999.2.6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
25 Toigo G, Situlin R, Ciocchi B. Gut and nutrients. Metabolism and Artificial Nutrition in the Critically Ill 1999. [DOI: 10.1007/978-88-470-2901-9_21] [Reference Citation Analysis]